Literature DB >> 20422578

Characterisation and monitoring of neutralisation-resistant VP2 phenotypes in BTV-1 isolates from northern Australia collected over a twenty-year period.

J R White1, V Boyd, J K Brangwyn, C J Duch, L I Pritchard, L F Melville, T D St George, B T Eaton.   

Abstract

Phenotypic profiles of the VP2 protein of isolates of bluetongue virus serotype 1 (BTV-1) collected from Queensland and the Northern Territory, Australia, between 1979 and 1986 were analysed using neutralising monoclonal antibodies (MAbs) raised to the prototype isolate of Australian BTV-1 collected in the Northern Territory in 1979. Two distinct profiles were found. Northern Territory isolates exhibited the prototype profile, yet those from Queensland had a significantly different ('resistant') profile. Nucleotide sequencing of gene segment 2 from both groups of isolates was undertaken. When the nucleotide sequences of isolates from a later period in each State were analysed (1997-2001), all exhibited the 'resistant' profile. Thus, a novel VP2 phenotype, already in existence in Queensland, had supplanted a pre-existing VP2 phenotype in the Northern Territory between the two periods. Furthermore, amino acid differences between the resistant and prototype VP2 proteins were analogous to amino acid substitutions known to be associated with neutralisation resistance. The host immune response may therefore have contributed to selection of the 'resistant' phenotype.

Entities:  

Year:  2004        PMID: 20422578

Source DB:  PubMed          Journal:  Vet Ital        ISSN: 0505-401X            Impact factor:   1.101


  2 in total

1.  Genomic analysis of putative novel serotypes of Tibet orbivirus isolated in Japan.

Authors:  Yuto Suda; Katsunori Murota; Hiroaki Shirafuji; Tohru Yanase
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

2.  Genetic characterization of the tick-borne orbiviruses.

Authors:  Manjunatha N Belaganahalli; Sushila Maan; Narender S Maan; Joe Brownlie; Robert Tesh; Houssam Attoui; Peter P C Mertens
Journal:  Viruses       Date:  2015-04-28       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.